| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,168 | 23,051 | 14,331 | 18,859 | | Cost of Revenue | 3,032 | 2,284 | 1,961 | 2,138 | | | Gross Profit | 22,136 | 20,767 | 12,370 | 16,721 | | | Operating Expenses | | Research Development | 15,300 | 13,557 | 12,267 | 10,236 | | Selling General and Administrative | 14,733 | 16,022 | 16,840 | 15,384 | | Non Recurring | 35 | 48 | 1,931 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,932) | (8,860) | (18,668) | (8,899) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 151 | 159 | 160 | 211 | | Earnings Before Interest And Taxes | (7,781) | (8,701) | (18,508) | (8,688) | | Interest Expense | 712 | 810 | 899 | 1,021 | | Income Before Tax | (8,493) | (9,511) | (19,407) | (9,709) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,493) | (9,511) | (19,407) | (9,709) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,493) | (9,511) | (19,407) | (9,709) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,493) | ($9,511) | ($19,407) | ($9,709) |
|
0.51% Nasdaq 
0.06 (1.01%) 
Income Statement
